Research Article
[Retracted] Analysis of Prognostic Factors and Treatment Modes of Patients with Recurrent Endometrial Carcinoma
Table 2
Univariate analysis on prognosis of REC patients (n (%) and mean ± SD).
| | Factors | n | Good prognosis (n = 70) | Poor prognosis (n = 30) | χ2/t | |
| | Age (years) | 0.433 | 0.511 | | <65 | 55 | 40 (57.14) | 15 (50.00) | | ≥65 | 45 | 30 (42.86) | 15 (50.00) |
| | Average age (years) | 100 | 63.02 ± 6.18 | 65.03 ± 5.36 | 1.548 | 0.125 |
| | FIGO stage | 5.630 | 0.131 | | I | 68 | 52 (74.29) | 16 (53.33) | | II | 17 | 11 (15.71) | 6 (20.00) | | III | 10 | 5 (7.14) | 5 (16.67) | | IV | 5 | 2 (2.86) | 3 (10.00) |
| | Radiotherapy and chemotherapy after primary surgery | 1.198 | 0.274 | | No | 26 | 16 (22.86) | 10 (33.33) | | Yes | 74 | 54 (77.14) | 20 (66.67) |
| | Infiltrating muscularis | 1.293 | 0.524 | | Without | 20 | 12 (17.14) | 8 (26.67) | | <1/2 | 24 | 18 (25.71) | 6 (20.00) | | ≥1/2 | 56 | 40 (57.15) | 16 (53.33) |
| | Pathological pattern | 5.372 | 0.021 | | Endometrioid adenocarcinoma | 78 | 59 (84.29) | 19 (63.33) | | Serous adenocarcinoma | 22 | 11 (15.71) | 11 (36.67) |
| | Pathological grade | 12.518 | 0.002 | | G1 | 28 | 25 (35.71) | 3 (10.00) | | G2 | 22 | 18 (25.71) | 4 (13.33) | | G3 | 50 | 27 (38.58) | 23 (76.67) |
| | DFI (months) | 11.020 | <0.001 | | <12 | 48 | 26 (37.14) | 22 (73.33) | | ≥12 | 52 | 44 (62.86) | 8 (26.67) |
| | Recurrence site | 1.786 | 0.181 | | Pelvic cavity | 40 | 31 (44.29) | 9 (30.00) | | Outside pelvic cavity | 60 | 39 (55.71) | 21 (70.00) |
| | Treatment mode after relapse | 5.530 | 0.019 | | DLT | 41 | 34 (48.57) | 7 (23.33) | | PC | 59 | 36 (51.43) | 23 (76.67) |
|
|
